Merck KGaA in Darmstadt, Germany, recently welcomed Hamilton Thorne and ZEISS as the two most recent members of the company’s Global Fertility Alliance, which already includes Illumina, Genea and Merck KGaA.
Leaders at the American Cancer Society (ACS) as well as the American Cancer Society Cancer Action Network (ACS CAN) recently announced that the agencies will increase their research funding by two times.
A recent federal analysis from the National Institutes of Health (NIH) shows that Americans have spent $30.2 billion out-of-pocket for complementary health methods, including meditation, herbal supplements, yoga and chiropractic services.
Takeda Pharmaceutical Company Limited recently announced that it has received a significant grant from the Bill & Melinda Gates Foundation to support Takeda’s ongoing polio eradication efforts, which are taking place in developing countries.
Leaders with the National Institutes of Health (NIH) and Fundacao Oswaldo Cruz-Fiocruz, a scientific research organization connected to the Brazilian Ministry of Health, recently enrolled approximately 10,000 women in a study about the Zika virus and pregnancy.
Leaders in the worldwide HAE community recently gathered at the 2016 CSL Behring event on May 16 to recognize the fifth annual HAE Day initiative from HAEi, a worldwide patient organization dedicated to C1-inhibitor deficiency.
The Michael J. Fox Foundation (MJFF) plans to partner with Georgetown University to offer a fellowship that will train students in the Georgetown Program for Regulatory Science and Medicine to optimize clinical trial designs and better support novel therapies.
National Cancer Institute initiative Genomic Data Commons recently launched at its operations center in the University of Chicago, from which it hopes to provide researchers with genomic and clinical data.
The ACS CAN recently supported a fiscal year 2016 spending bill markup from the Senate Appropriations Subcommittees on Labor, Health and Human Services and Education, which includes increases in cancer research spending.
A briefing, hosted by the Healthcare Leadership Council and sponsored by Takeda Pharmaceuticals USA Inc.-Lundbeck LLC and New York-Presbyterian Hospital, recently examined the costs associated with depression and the impact cognitive disorders pose to patients’ ability to function.
The U.S. House Committee on Energy and Commerce recently honored the end of Neurofibromatosis (NF) Awareness Month, held in May, by emphasizing the Child’s Tumor Foundation 'Shine a Light on NF' movement.